PBYI — Puma Biotechnology Share News
0.000.00%
Last trade - 00:00- $581.24m
- $487.34m
- $228.37m
Brief: Puma Biotechnology Announces $10 Mln Private Placement
U.S. STOCKS ON THE MOVE-Duolingo, Hibbett, Broadcom, VanEck
U.S. STOCKS ON THE MOVE-U.S. banks, Costco, Sweetgreen
U.S. STOCKS ON THE MOVE-Ocugen, Gap, Funko, Smith & Wesson
Puma Biotech gains on upbeat Q4 revenue, net profit
Puma Biotechnology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Puma Biotechnology Reports Q4 And Full Year Financial Results
Puma Biotechnology Inc expected to post a loss of 9 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Virgin Galactic, Delta Airlines, Deere & Co, Boeing
U.S. STOCKS ON THE MOVE-Boeing, Netflix, Rockwell Medical, Sinclair
U.S. STOCKS ON THE MOVE-Denali Therapeutics, ViacomCBS, Nikola, Vyne Therapeutics
U.S. STOCKS ON THE MOVE-Chip stocks, Delta Air Lines, Adagio Therapeutics, Mattel
Puma Biotechnology jumps as drug added to guideline for breast cancer treatment
Brief: Puma Biotechnology’s Nerlynx Included In Two Important NCCN Clinical Practice Guideline Updates
Brief: Puma Biotechnology Presents Updates From The Summit Trial At The 2021 Sabcs Annual Meeting
U.S. STOCKS ON THE MOVE-Nordstrom, Gap, HP Inc, Chevron
Puma Biotech jumps after U.S. patent term extension for cancer drug
Brief: Puma Biotechnology Announces U.S Patent Term Extension For Nerlynx® (Neratinib)
Brief: Puma Biotechnology To Present Neratinib Data At The San Antonio Breast Cancer Symposium (SABCS)